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Abstract. This article reviews emerging Raman techniques (Spatially Offset and Transmission Raman
Spectroscopy) for non-invasive, sub-surface probing in process control and forensic applications. New
capabilities offered by these methods are discussed and several application examples are given including
the non-invasive detection of counterfeit drugs through blister packs and opaque plastic bottles and the
rapid quantitative analysis of the bulk content of pharmaceutical tablets and capsules without
sub-sampling.
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INTRODUCTION
In a number of analytical applications in the pharmaceu-
tical industry it is a requirement that the chemical constitu-
ency of a product is analysed rapidly, non-destructively and
non-invasively with minimal sample preparation or pre-
treatment. Applications span the entire process from pro-
duction (process control) through to quality control and
counterfeit detection of packaged products.
Raman spectroscopy holds particular promise in this area
due to its inherent high chemical specificity (substantially
higher than that of near-infrared absorption (NIR) spectros-
copy), the ability to probe samples in the presence of water
and its potential for high penetration depth into non-
absorbing or weakly absorbing turbid samples such as
pharmaceutical powders (similar to that of NIR absorption
spectroscopy). The higher chemical specificity of Raman
spectroscopy relative to NIR absorption stems from the fact
that NIR spectra consist of broad (overlapping) overtone and
combination bands of fundamental vibrational modes. In
contrast, Raman spectra exhibit much sharper bands cor-
responding to fundamental vibrational modes (1). Although
the optical counterparts of Raman scattering (mid-infrared
(MIR) and terahertz (THz) spectroscopy) also offer high
chemical specificity, their applications are typically restricted
to dry samples due to strong water absorption. In addition,
MIR spectroscopy is generally only capable of probing very
thin layers of samples unless the samples are substantially
diluted. On the other hand, the Raman technique suffers
from high sensitivity to fluorescence which can swamp the
much weaker Raman signal. This problem can, however,
often be circumvented by using near-infrared excitation to
avoid excitation into fluorescing states (1).
The Raman effect is the inelastic scattering of photons
from molecules via interactions with the vibrational modes
within the molecule. In this process, the photon energy and
consequently the photon wavelength are altered (1) giving a
spectral signature unique to each chemical species undergoing
scattering. Most commonly the photon loses energy and its
wavelength is shifted, typically by several hundreds to
thousands of wavenumbers away from the laser wavelength,
towards longer wavelengths. The Raman shift, or energy loss,
is directly related to the frequencies of vibrational motion
activated within the molecule which are themselves highly
dependent on chemical constitution; thus the identity and
structure of the molecule can be deduced.
Historically, the Raman method has been used with
commercial Raman probes and microscopes predominantly in
the backscattering collection mode (see Fig. 1) although in a
number of specialist laboratories a 90° collection geometry
can also be found (1). The backscattering geometry is widely
used for its instrumental simplicity and ease of deployment.
Its major drawback is an inability to probe deep layers of
turbid samples such as pharmaceutical tablets or capsules (1)
where the effective probed depths are typically only a
millimetre or two (2).
Recently, a substantial increase of the Raman signal
penetration depth was accomplished by utilising the diffuse
component of light rather than the ballistic component (3). In
conjunction with temporal and spatial gating methods (and in
analogy with NIR absorption tomography (4–7) or fluores-
cence spectroscopy (8–11)) this allows Raman spectra of sub-
layers to be identified. These developments are beginning to
shed new light into the potential use of Raman spectroscopy
throughout the pharmaceutical industry from production and
quality control through to shelf-life determination and
counterfeit detection.
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These newly emerging developments, in common with
other more established spectroscopic techniques, require
statistical analysis to extract the required information (chem-
ical composition, concentration of analyte, etc.) from the
extensive, spectrally complex, datasets produced. While a
detailed review of the application of such multivariate
techniques to process monitoring and the pharmaceutical
industry in general is beyond the scope of this article, a brief
outline is useful. In spectroscopic terms, multivariate analysis
assumes a linear dependence between spectral response and
concentration which, in favourable cases, allows decomposi-
tion of a dataset (m spectra recorded in n wavelength
channels) into two simpler matrices corresponding to con-
centration (k by m) and pure spectra (k by n) where k is the
number of distinct analytes in the dataset. Additional
information from external sources (e.g. concentration from
“wet” chemical analysis) can be added to build calibration
models (e.g. using partial least squares (PLS) or principal
component regression (PCR)) which are subsequently ap-
plied to unknown samples for quantitative prediction. For a
more detailed overview of multivariate methods see (12).
METHODS FOR DEEP RAMAN SPECTROSCOPY
OF TURBID MEDIA
Temporal Gating
A major obstacle preventing conventional Raman spec-
troscopy from acquiring signals from deep areas of turbid
samples is the presence of intense Raman signals originating
from the surface layers of the probed sample which mask the
weaker subsurface signals. The Raman signals from deeper
zones are typically substantially diluted due to the wide
diffusion of laser and Raman photons away from the vicinity
of the collection/deposition area due to the long pathways
required to sample the target layer. The overwhelming
surface signals can be effectively discriminated against using
impulsive Raman excitation and fast (picosecond) temporal
gating of the backscattered Raman signal as demonstrated by
Wu et al. (13) who used a photon counting approach to
accomplish gated detection and imaging of a single Raman
component. The recovery of the full Raman spectrum of a
deeply buried layer in a turbid sample was demonstrated
using the Kerr gating approach by Matousek et al. (14) on a
two-layer powder sample; this work combined pioneering
research into Raman photon migration (Everall et al.
(15,16) and Morris et al. (17)) with fluorescence rejection
techniques (Matousek et al. (18–20)). A more extensive
description of these methods and their underlying mecha-
nisms can be found in (3). Although these methods were
demonstrated to be technically viable the instrumental com-
plexity and high peak intensities of ultrafast lasers precluded
their wider practical usage.
Spatially Offset Raman Spectroscopy
The instrumental complexity and laser intensity issues
were addressed through the development of a spatial
equivalent to temporal gating known as Spatially Offset
Raman Spectroscopy (SORS) (21,22). With this concept the
Raman spectra of individual sub-layers within a complex
multi-layer system can be isolated with a considerably smaller
and simpler experimental approach which replaces the
ultrafast laser with a continuous, low power diode laser and
removes the need for fast temporal gating or photon counting
(see Fig. 1).
The SORS concept is straightforward; Raman signal is
collected from areas that are spatially offset (by a distance
Δs) from the point of illumination (see Fig. 2a). The key point
is that spectra collected at each spatial offset contain different
relative contributions from sample layers located at different
depths due to the wider spread of photons originating from
deeper layers on the sample surface. The lateral offset also
effectively discriminates against photons propagating side-
ways within the surface layers as they exhibit a higher loss at
the air-to-sample interface than photons propagating through
deeper layers. Consequently, the SORS technique effectively
suppresses the interfering Raman (and fluorescence) signals
originating from the surface layers, e.g. capsule shell, enhanc-
ing, in relative terms, the sub-layer Raman signal, e.g. a
pharmaceutical product contained within the capsule shell.
The availability of a set of Raman spectra with varying
degrees of surface and subsurface contributions permits a
complete isolation of the Raman spectrum belonging to
individual layers. This can be accomplished using a variety
of numerical multivariate methods including band target
entropy minimization (BTEM) (23,24). For a “simple” two
layer system, this can also be achieved by a manual or
automated scaled subtraction of two SORS spectra obtained
at different spatial offsets to cancel the surface contribution
(25,26). This is in contrast with conventional backscattering
Raman spectroscopy where the solitary Raman spectrum
available is typically dominated by intense surface layer
components and no information is available to permit the
separation of the surface and subsurface Raman components
even if subsurface Raman signals are detectable. Elimination
of the surface layer with conventional Raman spectroscopy
can only be performed if the Raman spectrum of the pure
over-layers is known a priori and if the surface layer Raman
signal does not swamp the underlying subsurface Raman
component, conditions which are rarely satisfied simulta-
neously in deep subsurface Raman spectroscopy.
The SORS method was first demonstrated on a stratified
powder sample (21) and has been used since in numerous
practical applications including the non-invasive Raman
spectroscopy of bones (25), in pharmaceutical forensic
applications (27) and security screening (26). The first
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Fig. 1. Basic types of Raman spectroscopy geometries with respect to
the sample: Conventional backscattering Raman, SORS and Raman
transmission geometries. R Raman light, L laser beam.
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posed of a 1 mm thick PMMA powder layer placed on top of
a layer of trans-stilbene powder (21). The results of these
measurements are shown in Fig. 3. The conventional Raman
spectrum is represented by the zero-offset. The introduction
of the spatial offset leads to a much faster decay of the surface
layer Raman signal (PMMA) compared with the sub-layer
(trans-stilbene). The article reports an improvement in
subsurface-to-surface relative Raman intensity by a factor of
19 at a spatial offset of 3.5 mm (21).
In order to maximise the signal quality the SORS con-
cept is often combined with a fibre optic collection scheme
developed for conventional Raman spectroscopy by Ma and
Ben-Amotz (28). In this scheme fibres collecting Raman sig-
nal from the sample are arranged in a ring or disk pattern and
are re-organised on the spectrograph slit into a linear pattern
matching the spectrograph slit geometry (21,22,29–31). Similar
concepts were also used in fluorescence tomography (8–11).
A simple variant of SORS implementable on conven-
tional Raman systems was recently described by Eliasson et
al. (32) and relies on defocusing a conventional Raman
collection system to induce a change in the relative Raman
contributions from surface and subsurface layers. Although
less effective than conventional SORS it can be used with less
challenging samples and provides a convenient first stepping
stone for researchers in possession of conventional Raman
instruments wishing to initiate research in this area.
More recently a refined SORS method, inverse SORS,
was developed permitting the use of higher overall laser
powers through the provision of much wider illumination
zones on the sample. This concept is particularly beneficial
when probing living tissue in vivo or pharmaceutical samples
in explosive powder environments where stringent illumina-
tion intensity limits exist.
The inverse SORS concept was demonstrated indepen-
dently by Matousek (33) and Schulmerich et al. (34,35). In
contrast to conventional SORS, this approach is based on the
collection of Raman light through a group of fibres contained
within the centre of a probe and the delivery of the laser
beam through a ring shaped beam area. The ring radius of the
beam defines the SORS spatial offset. The concept also
permits the setting of an arbitrary illumination radius
enabling better tailoring of the experimental conditions to
sample parameters than with conventional SORS probes
where collection ring radii are built into the fibre probe and
their radius cannot be altered by simple means. The ring-
shaped laser beam is typically generated using a conical lens
(axicon) (36) and the spatial offset is set by adjusting the
distance of the axicon from the sample (33) or by varying the





























Fig. 3. A set of SORS spectra collected from a two-layer system
consisting of 1 mm-thick layer of PMMA made of 20 μm-diameter
spheres followed by a 2 mm-layer of trans-stilbene powder measured
using 514 nm as the probe wavelength. The spectra are shown for
different spatial offsets. The top and bottom spectra are those of the
individual layers obtained in separate measurements. The spectra are
offset for clarity. The acquisition time was 100 s for each spectrum
and the average laser power 12 mW. (Reprinted with permission from
P. Matousek, I. P. Clark, E. R. C. Draper, M. D. Morris, A. E.
Goodship, N. Everall, M. Towrie, W. F. Finney and A. W. Parker,















Fig. 2. Schematic diagram of a basic implementation of a the SORS
and b transmission Raman geometries.
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Transmission Raman
Another deep Raman spectroscopy concept, related to
SORS, uses a transmission geometry to provide information
on the bulk content of samples through a single Raman
exposure (2). In this method, the laser beam impacts on one
side of the sample and the Raman signal is collected from the
opposite side (see Fig. 1). Although the transmission Raman
technique was demonstrated in the very early days of Raman
spectroscopy (37), its benefits for the non-invasive probing of
the bulk content of pharmaceutical products have not been
recognised. In particular, these include the removal of the
sub-sampling problem (38) (the inability to probe deeper
layers of turbid samples) and the effective suppression of
interfering fluorescence and Raman signals originating from
surface layers (39). This concept can be considered to be a
special case of SORS with the illumination and collection
points displaced to the maximum extent.
Sub-sampling is a particular obstacle for conventional
backscattering Raman spectroscopy of pharmaceutical formu-
lations which are often highly heterogeneous (38). To reduce
this effect, special devices for rotating pharmaceutical tablets in
front of a conventional backscattering Raman spectrometer are
used. More recently a large illumination probe was developed
by Kaiser Optical Systems (PhAT) to minimise this issue by
collecting Raman signal from a large surface area of the sample
although the penetration depth of this concept is still insufficient
to provide bulk information on a typical tablet or capsule (2).
The transmission Raman concept (see Fig. 2b) eliminates
the need for any special rotators as it inherently provides the
Raman signal originating from the entire bulk of the probed
object. With this concept, bulk information on a tablet or
capsule can be obtained rapidly within a single spectral
acquisition permitting a rapid deployment of this method in
process analytical applications on production lines.
The elimination of the sub-sampling problem in this
geometry was confirmed by Monte Carlo simulations by
Matousek and Parker (2). The results of this study are shown
in Fig. 4 and illustrate that if a thin ‘impurity’ layer is re-
located from the surface to a depth of 3 mm within a typical
tablet medium its conventional backscattering Raman signal
is diminished by 4 orders of magnitude. In practical terms,
such signal is lost in the dominant Raman signal originating
from the surface layers. On the other hand, in the transmis-
sion Raman geometry the signal is largely insensitive to the
depth from which it originates.
The experimental demonstration of the elimination of
the sub-sampling problem was carried out by Matousek and
Parker (2) on a standard paracetamol tablet of 3.9 mm
thickness with a simulated impurity layer (2 mm trans-stilbene
powder layer) placed either in front or behind the tablet
relative to the illuminating laser beam. The measurements
were performed using an 830 nm probe, with a laser beam
diameter of 4 mm. The results are shown in Fig. 5 and
demonstrate a strong sub-sampling problem in the conven-
tional geometry which yields predominately Raman signa-
tures of the surface layers probed by the instrument. In
contrast, the transmission geometry provided Raman signals
originating from both the tablet and the ‘impurity’ and their
relative intensity was largely independent of the position of
the impurity relative to the tablet; a result in good agreement
with the theoretical simulations.
Due to the passage of photons through the entire
thickness of tablet the overall Raman signal in the transmis-
sion mode is smaller than in the backscattering geometry.
Intuitively, one might assume that it would be negligible given
the tablet thickness. However, the observed signal diminish-
ment for a typical tablet of 3.9 mm thickness was observed to
be only a factor of 12. The fact that a relatively high level of
Raman signal remains after propagating through such a thick
turbid medium is due to the fact that the Raman component
diminishes more slowly than its elastic (laser) counterpart;
while both components exhibit decay due to photon diffusion,
the Raman component is partially regenerated from the laser
component (Everall et al. (15)).
Enhancement of the transmission Raman signal, if
desired, can be accomplished by increasing either the laser
power (which is permitted by the relatively large illumination
areas possible with the transmission geometry) and/or using
‘unidirectional’ coupling mirrors as described below (40).
These improvements have the potential to reduce acquisition
times to fractions of a second in many practical situations
making transmission Raman spectroscopy an attractive can-
didate for many PAT applications.
In many applications, it is also beneficial that the
transmission Raman method inherently suppresses fluores-
cence emission originating from the surface layers of the
probed sample, in contrast, with the conventional backscat-
tering Raman geometry which accentuates such interfering
signals (39).
Raman Signal Enhancement Using a ‘Unidirectional’ Mirror
When probing pharmaceutical tablets, Raman signals in
SORS and transmission Raman spectroscopy can be substan-
tially enhanced using a ‘unidirectional’ mirror (Matousek
(40)) leading to higher spectral quality, enhanced penetration
depth and shorter acquisition times. The special mirror



















































Fig. 4. Plot of Raman intensities for the backscattering and transmission
geometries versus depth (d1) of the inter-layer (impurity) within a
pharmaceutical tablet-like medium. The dependencies are the results of
Monte Carlo simulations. (Reprinted with permission from P. Matousek,
A.W. Parker, Appl. Spectrosc. 2006, 60, 1353–1357. Copyright (2006)
The Society for Applied Spectroscopy (2)).
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laser illumination zone in close proximity to the sample. The
element is in essence a narrow bandpass filter designed to
transmit semi-collimated laser radiation at normal incidence.
The concept is based on the angular dependence of the
dielectric filter spectral properties on impacting photon
direction. This spectral profile shifts to lower wavelength
with increasing deviation of photons away from normal
incidence and enables the element to act as a unidirectional
mirror passing a semi-collimated laser beam through unhin-
dered at one side whilst, at the other side, reflecting photons
emerging from the sample at random directions (mostly away
from normal incidence). This prevention of photon loss,
which is often the dominant photon loss mechanism, leads
to a substantial increase of the overall Raman signal. In its
basic form, the method requires that the coupling sample
surface is not heavily curved. Consequently the method,
without taking any further measures, is readily applicable to
flat pharmaceutical tablets while much lower effectiveness is
observed for curved objects such as capsules.
Figure 6 shows the results of a feasibility experiment
carried out in transmission Raman geometry on a standard
paracetamol tablet with and without a bandpass filter
(transmission centered at 830 nm with bandwidth (FWHM)
of 3.2 nm). An eight-fold enhancement was observed upon
the insertion of the bandpass filter into the proximity of a
two-layer powder sample. The enhancement was observed to
be present for both layers with the surface layer experiencing
slightly larger enhancement, by about 13%.
Such large enhancements could be difficult, and in many
cases impossible, to reproduce by other means. It is also
worth noting that the signal enhancement is uniform across
the entire spectrum and no spectral fluctuations are present.
The presence of enhancement was also experimentally























































Fig. 6. The experimental demonstration of the Raman signal enhance-
ment concept on a two-layer system. The Raman spectra were obtained
from a two-layer sample composed of a 3.8 mm thick paracetamol
tablet (P) and 2 mm thick trans-stilbene powder layer (T) in
transmission geometry. The trans-stilbene layer was facing the Raman
collection system and the bandpass filter BF was in contact with the
paracetamol tablet. a Raman spectra measured with (with BF) and
without (bare) the bandpass filter BF. A difference spectrum (difference)
obtained by scaled subtraction of the Raman spectra with and without
the enhancing filter cancelling the trans-stilbene contribution is also
shown. The residual spectrum is that of paracetamol indicating that this
layer has experienced somewhat higher enhancement. b The depen-
dence of Raman signal enhancement factor of the two individual layers
on the distance of the bandpass filter from the sample. The acquisition
times in all the measurements were 0.5 s with a laser power of 250 mW
(830 nm). The spectra are offset for clarity. (Reprinted with permission
from P. Matousek, Appl. Spectrosc. 2007, 61, 845–854. Copyright (2007)
The Society for Applied Spectroscopy (40)).











































Fig. 5. The Raman spectra obtained from a two-layer sample
(3.9 mm thick paracetamol tablet and 2 mm thick trans-stilbene
powder ‘impurity’ layer) using a conventional backscattering geom-
etry and b transmission geometry. The measurements are performed
at two sample orientations, with paracetamol at the top and bottom of
the trans-stilbene cell as indicated in the graphs. The top and bottom
spectra are those of paracetamol and trans-stilbene, respectively,
obtained in separate experiments. The acquisition times were
between 0.2 and 10 s, with a laser power of 80 mW. The spectra are
offset for clarity. P paracetamol, T trans-stilbene, R Raman light, L
laser beam. (Reprinted with permission from P. Matousek and A.W.
Parker, Appl. Spectrosc. 2006, 60, 1353–1357. Copyright (2006) The
Society for Applied Spectroscopy (2)).
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at the detection limit was enhanced and its signal to noise
substantially improved (41).
EXAMPLES OF PHARMACEUTICAL APPLICATIONS
Forensic Applications
One major area where SORS has proved to be particu-
larly useful is the authentication of pharmaceutical products
through non-invasive chemical analysis of the content of
opaque plastic bottles and other types of packaging. The
method offers a unique potential to inspect and chemically
identify products throughout the entire supply chain in a
non-invasive and non-destructive manner. The need for
such inspection has heightened in recent years with the
increase of counterfeit products on the market (42). The
targeted drugs in the developed world often include lifestyle
drugs and drugs for chronic diseases. More seriously, in
Africa and Asia, it is the essential life-saving medicines, such
as anti-infective drugs, which are plagued by this growing
problem (43–45).
Raman techniques offer an attractive alternative to
current methods (principally NIR spectroscopy) in which
subtle spectral differences in composition are often hard to
detect and chemometric tools are routinely required for data
interpretation. In addition, NIR cannot be deployed non-
invasively in many cases because of the interference and
absorption of NIR signal by common packaging materials.
As an alternative technique, Raman spectroscopy pro-
vides substantially higher chemical specificity and better
penetration depth. The method in its conventional form
permits the interrogation of many pharmaceutical products
through their coatings or capsules as well as through blister
packs and has also been used to detect counterfeit drugs (46).
However, in many instances, and in particular with darkly
colored coatings or capsules, or opaque packaging, the
Raman signal of the API can be heavily polluted with
fluorescence and Raman signals originating from the coating,
capsule (39) or blister pack itself. The interfering signals
reduce the sensitivity of the technique and can preclude the
observation of the API and other ingredients altogether.
Recently Eliasson and Matousek (27,47) demonstrated
that SORS can provide a chemical signature of the internal
content of opaque plastic containers. This is demonstrated in
Fig. 7 for aspirin tablets held inside an opaque (white) plastic
pharmaceutical bottle (1.3 mm thick). The conventional
Raman signal is overwhelmed by the Raman component
originating from the container wall and is consequently
ineffective in determining the contents of the bottle. In
contrast, the SORS method using a scaled subtraction of
two SORS spectra measured at different spatial offsets yields
a clean Raman spectrum of the tablets inside the bottle. The
experiments were performed at 830 nm with a 250 mW laser
beam and an acquisition time of 1 s.
More recently, SORS was also used in the detection of
counterfeit anti-malarial tablets by Ricci et al. (48). As the
SORS concept can be readily incorporated into existing
commercial hand-held Raman instruments it holds great
promise for more accurate and sensitive interrogation of
drugs throughout the entire supply chain.
Probing of Pharmaceutical Tablets and Capsules in Process
Control
A number of pharmaceutical process analytical technol-
ogy (PAT) applications require the monitoring of the bulk
content of pharmaceutical products. Ideally, this should be
accomplished quickly, non-destructively and non-invasively
with high chemical specificity. Although NIR absorption
spectroscopy is widely used in this area, in a number of
applications it has insufficient chemical specificity and is
hampered by the presence of water. In addition, tablet
coatings and capsule shells, in particular those containing
TiO2, can present an insurmountable challenge. As discussed
earlier the transmission Raman approach effectively over-
comes such hurdles (2) making it a formidable contender for
displacing NIR absorption spectroscopy in number of appli-
cation areas.
A study by Matousek and Parker (39) demonstrates that
the transmission Raman geometry also dramatically reduces
fluorescence interference originating from surface layers of
the probed sample, thus permitting more sensitive spectro-
scopic interrogation of the internal capsule chemical content.
The results of comparative measurements using transmission
and conventional Raman geometries on a variety of coloured
capsules are shown in Fig. 8. The spectra are displayed in
their raw form with no background subtraction. The data
demonstrates that interfering surface fluorescence, for many
coloured capsules, significantly deteriorates the overall qual-
ity of conventional Raman spectra. On the other hand, the
transmission Raman method effectively reduces this interfer-
ence permitting much more sensitive measurement of the
internal content.
Fig. 7. Non-invasive Raman spectra of aspirin tablets measured
through a white, diffusely scattering 1.3 mm thick plastic container.
Conventional Raman and the scaled and subtracted SORS data are
shown together with the reference Raman spectra of aspirin and the
plastic container. The conventional Raman spectrum is dominated by
the Raman signal of the container masking the Raman signal of the
aspirin contents. The acquisition time was 1 s and the laser beam
power 250 mW.
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The ability of the transmission Raman approach to
determine the quantitative chemical composition of pharma-
ceutical tablets and capsules was recently demonstrated by
Johansson et al. (49) using 20 test tablets of thickness 3.3 mm
prepared under laboratory conditions. In this study the active
pharmaceutical ingredient (API) was quantified with a
relative root mean square error of prediction of +/−2.2% in








































































































































































































































































































































Fig. 8. The comparison of performance of the conventional backscattering and transmission Raman geometries in probing various
pharmaceutical capsules. The acquisition times were 10 s unless indicated otherwise, with a laser power of 80 mW. Asterisk designates Raman
band originating from capsule shell. (Reprinted with permission from P. Matousek, A.W. Parker, Non-Invasive Probing of Pharmaceutical
Capsules using Transmission Raman Spectroscopy, J. Raman Spectrosc. 2007, 38, 563–567. Copyright (2007). © John Wiley & Sons (39)).
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regression. The acquisition time was 10 s with a laser power
of 400 mW (785 nm). The measurements were also per-
formed in a conventional backscattering Raman geometry
which yielded a lower relative accuracy of +/−2.9% under the
same conditions. This was ascribed to the presence of strong
sub-sampling in conventional backscattering Raman spectros-
copy and its absence with the transmission geometry. This
was demonstrated on the analysis of an outlier spectrum
present in the conventional backscattering Raman measure-
ments that showed a clear deviation from the expected
profile expected from the nominal concentration. No such









































Fig. 9. Prediction of the concentration of propranolol tablets in two
independent test sets; the original test sets (solid circles) and the
exchanged test sets (open circles). Comparison of A Raman
transmission (1 PLS component) and B Raman backscatter (1 PLS
component). (Reprinted with permission from J. Johansson, A.
Sparen, O. Svensson, S. Folestad, M. Claybourn, Appl. Spectrosc.




















Fig. 10. Model robustness: the effect of reducing the number of
samples in calibration models on the prediction errors for indepen-
dent test sets. Solid circles represent the transmission mode while
open circles represent the backscatter mode. The figure shows mean
values of RMSEP for reduced models built on the original and the
exchanged models, and the error bars show max and min values of
RMSEP. The same test set was used for all reduced models
originating from the same full model. (Reprinted with permission
from J. Johansson, A. Sparen, O. Svensson, S. Folestad, M.
Claybourn, Appl. Spectrosc. 61, 1211–1218 (2007). Copyright (2007)
The Society for Applied Spectroscopy (49)).
















Fig. 11. Non-invasive Raman spectra of capsules. The spectra were
obtained using a laboratory instrument configured in the transmission
Raman geometry and a standard commercial Raman microscope
(Renishaw) in conventional backscattering geometry. The Raman
spectra of an empty capsule shell (lowest trace) and the capsule
content itself (top trace, the capsule content was transferred into an
optical cell) are shown for comparison. The dashed lines indicate the
principal Raman bands of the capsule and of the API. (This figure
was published in J. Pharm. Biomed. Anal., in press, C. Eliasson, N.A.
Macleod, L. Jayes, F.C. Clarke, S. Hammond, M.R. Smith, P.
Matousek, Non-Invasive Quantitative Assessment of the Content of
Pharmaceutical Capsules using Transmission Raman Spectroscopy,
Copyright Elsevier (2008) (50)).
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unexpected outlier was observed in the transmission geom-
etry. It should be noted that the higher accuracy in the
transmission mode was achieved despite the lower (by a
factor of 10) overall Raman signal intensity. The method
was also applied to pharmaceutical capsules yielding a
relative accuracy of +/−3.6%.
The study also indicates that the transmission Raman
mode requires a leaner calibration model (only one latent
variable was required) compared with conventional backscat-
tering Raman. The model was robust enough to provide
relatively accurate predictions when only two or three spectra
were used as calibration data (see Fig. 10).
In parallel research, the feasibility of quantifying the
content of production line type samples prepared in a
laboratory environment was demonstrated by Eliasson et al.
(50). The study used 150 capsules and established the
feasibility of quantifying the active pharmaceutical ingredient
to within a relative error of 1–2% in transmission Raman
mode. The measurements were performed through capsules
containing a high level of TiO2 which prevents accurate
analysis by other techniques (including conventional Raman
and NIR absorption). The adoption of the transmission
concept led to the suppression of this interfering signal by
a factor of 33 (see Fig. 11) permitting the quantification of
the API with a relative root mean square error of +/−1.2%
with 5 s acquisition time (see Fig. 12) per capsule. The
reduction of the acquisition time to 1 s yielded still acceptable
accuracy with the relative root mean square error increasing
to +/−1.8%.
The inherent properties of the transmission geometry
approach (bulk probing, gross insensitivity to alignment,
suppression of interfering surface layers and non-invasive/
non-destructive probing) combined with the ability to rapidly
acquire high quality spectra (within a fraction of a second)
make the technique potentially well suited for implemen-
tation on production lines where both partial or complete
inspection of samples is required. The handful of published
studies has provided a glimpse of the potential of the
technique; further research is required to provide a detailed
comparison with other, more established methods (e.g. NIR)
in terms of signal to noise, linearity, specificity and
selectivity.
CONCLUSIONS
The emerging non-invasive, deep Raman spectroscopic
techniques described in this article promise to impact on a
variety of pharmaceutical analytical areas including quality
and process control and the authentication of pharmaceu-
tical products. Spatially Offset Raman Spectroscopy allows
the chemical signature of pharmaceuticals to be obtained
non-invasively through packaging materials for detection of
counterfeit drugs and determination of shelf-life. Transmis-
sion Raman provides information on the bulk content of
pharmaceutical tablets and capsules with effective suppres-
sion of interfering surface Raman and fluorescence signals
allowing the rapid construction of calibration models for
quantitative analysis. Signal enhancements of up to an order
of magnitude can be obtained by the use of dielectric
mirrors.
Perhaps most importantly, these techniques are experi-
mentally straightforward and are readily implementable on
commercial spectrometers. Although only briefly touched
upon in this review, the plethora of multivariate techniques
(12) applied to common spectroscopic methods (NIR, MIR
etc.) are equally applicable to the results of SORS and
transmission Raman providing a powerful tool for both
quantitative and qualitative analysis.
Probing of deep sub-layers with Raman spectroscopy is
very much a recent development and further validation
studies are required to quantify, and perhaps extend the
technical limitations and better define its potential. Many new
and exciting applications are already visible on the horizon
promising yet deeper penetration of optical analytical tech-
niques into pharmaceutical production and post-production
environments.
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Fig. 12. Partial least squares (PLS) calibration of the API dataset (5 s
accumulation time). Spectra were baseline corrected, normalised to
unit length and mean-centered. The dataset was randomly split into a
calibration set (two thirds) and a prediction set (one third); obvious
outliers from the PCA analysis were excluded from the analysis.
Predicted versus measured API concentration of the prediction set,
the solid line represents the 45° diagonal while the dotted lines show
the limits of the root mean square error of prediction. (This figure
was published in J. Pharm. Biomed. Anal., in press, C. Eliasson, N.A.
Macleod, L. Jayes, F.C. Clarke, S. Hammond, M.R. Smith, P.
Matousek, Non-Invasive Quantitative Assessment of the Content of
Pharmaceutical Capsules using Transmission Raman Spectroscopy,
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